7406 results for "canc*"

in 25.76 milliseconds.

• Rectal Cancer Samples Data Access Committee

  Dac EGAC00001001034

• University of Florida Brain Cancer DAC

  Dac EGAC00001001035

• University Clinic Erlangen/ German Cancer Research Center rare tumors data access committee

  Dac EGAC00001001053

• Age-related remodeling of apparently normal esophageal epithelia by common cancer drivers

  Dac EGAC00001001067

• SNP array datas of "Matched" cancer/PNE

  Dac EGAC00001001069

• DAC for study: Evaluation of commercial Guardant360 ctDNA test in metastatic prostate cancer

  Dac EGAC00001001082

• DAC for Familial Breast Cancer study EGAS00001003305

  Dac EGAC00001001087

• DAC for study Non-coding RNAs in Breast Cancer

  Dac EGAC00001001090

• DAC for study: "Circulating tumour DNA abundance and potential utility in de novo metastatic prostate cancer"

  Dac EGAC00001001099

• DAC for Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines

  Dac EGAC00001001101

• Radboudumc Cancer Genomics DAC

  Dac EGAC00001001102

• DAC for MCO colorectal cancer genomics at UNSW

  Dac EGAC00001001122

• DAC for Genomic characterization of metastatic breast cancers

  Dac EGAC00001001129

• Korean Advanced Thyroid Cancer Data Access Commitee

  Dac EGAC00001001151

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001154

• Leeds Cancer Genomics

  Dac EGAC00001001156

• Children's Cancer Therapy Development Institute Data Access Commitee

  Dac EGAC00001001160

• Stanford Data Access Committee for Multi-Region WES of Metastatic Colorectal Cancer

  Dac EGAC00001001164

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001165

• The data access committee for genome-wide cell-free DNA fragmentation in patients with cancer

  Dac EGAC00001001180

• OSBREAC (Oslo Breast Cancer Research Consortium)

  Dac EGAC00001001186

• Latency and interval therapy affect the evolution in metastatic colorectal cancer.

  Dac EGAC00001001198

• Gastric Cancer Pan-genome Data Access Commitee

  Dac EGAC00001001211

• Immune and Metabolic Features of Brain Metastases Melanoma (Cancer Discovery) Data Access Committee

  Dac EGAC00001001216

• Ewha-Samsumg Lung cancer collaboration DAC

  Dac EGAC00001001237

• DAC for Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness

  Dac EGAC00001001250

• UT MD Anderson Cancer Center Genomic Medicine and Leukemia

  Dac EGAC00001001252

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001001272

• SMC Colon cancer team

  Dac EGAC00001001277

• DAC for GAMuT Project - Peter MacCallum Cancer Centre

  Dac EGAC00001001278

• Charbonneau Cancer Institute DAC

  Dac EGAC00001001280

• Ewha-Samsung Lung cancer collaboration DAC

  Dac EGAC00001001283

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001285

• High-grade serous ovarian cancer (MDACC) data access committee

  Dac EGAC00001001288

• DAC for HSTCL study. National Cancer Centre Singapore.

  Dac EGAC00001001302

• DAC for Angiosarcoma Study. National Cancer Centre Singapore.

  Dac EGAC00001001311

• DAC for MEITL study. National Cancer Centre Singapore.

  Dac EGAC00001001323

• The data access committee for Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer

  Dac EGAC00001001331

• UCL Cancer Institute Data Access Committee

  Dac EGAC00001001360

• ASAN Center for Cancer Genome Discovery Data Access Commitee

  Dac EGAC00001001391

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001404

• The University of Hong Kong Colon Cancer Organoids Genomics Study Data Access Committee

  Dac EGAC00001001405

• Cancer Sequencing Data Access Committee

  Dac EGAC00001001428

• Data access committee for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

  Dac EGAC00001001435

• Cancer Data Access Commitee

  Dac EGAC00001001436

• Yale Cancer Center Data Access Commitee

  Dac EGAC00001001437

• Hyperpolarized 13C MRI in breast cancer DAC

  Dac EGAC00001001438

• Prostate Cancer Biobank Insbruck DAC

  Dac EGAC00001001463

• Metastases of a cancer of unknown primary (CUP)

  Dac EGAC00001001484

• Single Cell RNAseq of blood and tumor from renal cancer patients

  Dac EGAC00001001494

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001500

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001505

• The data usage policy for epigenomic profile of diverse cancer

  Dac EGAC00001001540

• Hereditary Cancer Diagnostics with I2HCP Data Access Comitee

  Dac EGAC00001001541

• Breast cancer bone metastases

  Dac EGAC00001001548

• Inherited Predisposition to Cancer Projects Data Access Committee

  Dac EGAC00001001565

• DAC for Phylogenetic reconstruction of breast cancer

  Dac EGAC00001001572

• Children's Cancer Therapy Development Institute DAC

  Dac EGAC00001001581

• Nicola Murray Centre for Ovarian Cancer Research Data Access Committee

  Dac EGAC00001001588

• DAC Barretos Cancer Hospital

  Dac EGAC00001001592

• Immunogenomics of Colorectal Cancer Data Access Committee

  Dac EGAC00001001596

• UZ Ghent Prostate Cancer Team Data Access Committee

  Dac EGAC00001001608

• Mutational Study Committee of a Taiwanese Lung Cancer Cohort (MSCTLCC)

  Dac EGAC00001001614

• Data access policy for PDTX Breast Cancer RNA-seq data from Ros et al (2020)

  Dac EGAC00001001620

• Data Access Committee of divisions B060 and B062, German Cancer Research Center (DKFZ)

  Dac EGAC00001001626

• Cancer Clinical Research Trust DAC for WES of HER2+ metastatic cancer samples

  Dac EGAC00001001632

• Primary tumor and metastatic breast cancer data access

  Dac EGAC00001001687

• Cancer Alliance Data Access Committee

  Dac EGAC00001001641

• INSERM U981 Team : Genomics of Non-Melanoma Skin Cancer

  Dac EGAC00001001644

• Princess Margaret Head and Neck Cancer Data Access Committee

  Dac EGAC00001001647

• NKI (Netherlands Cancer Institute)

  Dac EGAC00001001648

• Spatial Characterization Breast Cancer

  Dac EGAC00001001673

• Zero Childhood Cancer

  Dac EGAC00001001683

• DAC for Stuttgart Breast Cancer Cohort

  Dac EGAC00001001693

• Detection of ctDNA in Plasma of Patients with Clinically Localised Prostate Cancer is Associated with Rapid Disease Progression

  Dac EGAC00001001718

• Gene expression and Cancer

  Dac EGAC00001001727

• MyBrCa Tumour Genomics DAC

  Dac EGAC00001001740

• Lung cancer TRM Data Access Commitee

  Dac EGAC00001001759

• Cancer Research UK manchester Institute Cancer Biomarker Centre

  Dac EGAC00001001765

• Gene expression and Cancer

  Dac EGAC00001001772

• Data Access Commitee of Nanjing Medical University Affiliated Jiangsu Cancer Hospital

  Dac EGAC00001001774

• Access to aligned sequencing data for study "Loss of SNAI2 in prostate cancer correlates with clinical response to androgen deprivation therapy".

  Dac EGAC00001001809

• Imperial College Tumour Immunology group - Surgery and Cancer DAC

  Dac EGAC00001001814

• Long-read isoform in breast cancer - Data Access Commitee

  Dac EGAC00001001821

• AGECAN - DAC (Interespecies conservation of brain specific DNA methylation in aging and cancer)

  Dac EGAC00001001840

• PBL Cancer Data Committee

  Dac EGAC00001001870

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001906

• Division of Cellular Signaling National Cancer Center Research Institute

  Dac EGAC00001001909

• DAC Panel Evaluation

  Dac EGAC00001001914

• Data access committee for lung cancer

  Dac EGAC00001001942

• 4C Ovarian Cancer Data Access Committee

  Dac EGAC00001001953

• Singapore Gastric Cancer Consortium Data Access Committee

  Dac EGAC00001001955

• 4C Endometrial Cancer Data Access Committee

  Dac EGAC00001001956

• HER2-negative primary breast cancers WES

  Dac EGAC00001001973

• Breast Cancer Single-Cell Data Access Committee

  Dac EGAC00001001974

• BCRC-ICGS (Bladder Cancer Research Centre, Institute of Cancer and Genomic Sciences, Univ. of Birmingham) Data Access Committee

  Dac EGAC00001001982

• Peter MacCallum Cancer Centre Research Data Access Committee

  Dac EGAC00001001988

• Whole Exome Sequencing of Mixed Histology Lung Cancer at MDACC

  Dac EGAC00001002034

• Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee

  Dac EGAC00001002007

• bladder cancer data access commitee

  Dac EGAC00001002016